NEW YORK (GenomeWeb News) – Startup firm Norton Scientific separately announced an agreement to expand its sales presence in Europe and a deal for the sale of its products in the mid-Atlantic region.
Earlier this month, the company based in Thorold, Canada, announced a mutual distribution agreement under which AstraNet Systems, in Cambridge, UK, would sell Norton's recently launched protein aggregation monitoring, or PAM, hand-held system for the analysis of how proteins aggregate in solutions.
In return, Norton will promote the AstraGene UV low volume spectrophotometer for nucleic acid and proteins through its North American sales network.
In a separate announcement, Norton said this week it has signed up Columbia, Md.-based Advanced Scientific Technologies to sell the PAM and AstraGene products in the District of Columbia, Maryland, Delaware, Virginia, south and central Pennsylvania, and south New Jersey.
Financial and other terms of the two deals were not disclosed.
Norton was founded in 2010 and designs and develops products for proteomics research. The company said on its website that it also is developing its IP base in mechatronic systems, microfluidics, guided wave optical detection, multivariate analysis software for real-time process control, and macromolecular and nanoparticle separations.